Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition, Bristol-Myers Squibb will ...

While semaglutide works by hampering appetite and controlling blood sugar levels by mimicking the GLP-1 hormone, cagrilintide ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

This review highlights the key areas of research in the hypothalamic control of appetite. The hypothalamus consists of several nuclei that integrate peripheral signals, such as adiposity and ...

Kara Anderson, a researcher in endocrinology and metabolism at Virginia and lead author of the paper, says high-intensity exercise has the greatest effect on appetite, her study showing that ...

Expert Rev Clin Pharmacol. 2010;3(1):73-88.